LAWRENCE, Mass., Oct. 18, 2018 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, announced new findings demonstrating ...

NxStage Medical, a medical technology outfit focused on advancing renal care, has received clearance from the FDA for its System One, which allows for solo home hemodialysis, without a care partner, ...

NxStage Medical (NASDAQ: NXTM) has revolutionized the way that dialysis patients receive treatment, with its home-dialysis devices offering a much more convenient alternative to visiting outpatient ...

The home-dialysis market is a growing one because of the rise in incidence of diabetes and other diseases that can have an impact on kidney function. NxStage Medical (NASDAQ: NXTM) has done its best ...

NxStage Medical Inc. and Spindial S.p.A., a distributor of renal care products in Italy, announced a partnership with the Niguarda-Ca’ Granda hospital in Milan assist hemodialysis patients. The ...

WALTHAM, Mass., Aug. 25, 2022 /PRNewswire/ -- Fresenius Medical Care North America's (FMCNA) Renal Therapies Group today announced the availability of Speedswap ®, a new option for the NxStage ® ...

Medical device firm NxStage Medical Inc. says that it has raised $43 million through private placement of its common stock and warrants. Officials at Lawrence-based NxStage (Nasdaq: NXTM) said the ...